Top Markets
Coin of the day
Becton, Dickinson and Company Becton, Dickinson and Company

Becton, Dickinson and Company

BDX
Hisse Senetlerindeki Sıralama #389
Becton, Dickinson and Company develops, manufactures, and sells medical... Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.
Hisse Fiyatı
$154.51
Piyasa Değeri
$55.98B
Değişim (1 gün)
-1.82%
Değişim (1 yıl)
-32.08%
Ülke
US
Ticaret Becton, Dickinson and Company (BDX)

Kategori

Becton, Dickinson and Company (BDX) için kazanç
Dec 2025 itibarıyla kazanç TTM: $2.06B
Becton, Dickinson and Company şirketinin en son finansal raporlarına göre, mevcut kazancı $2.06B'dir. 2024 yılında şirket $2.01B kazanç elde etti, bu 2023 yılındaki $1.66B kazanca göre önceki yıla göre artış. Bu sayfada gösterilen kazanç, faiz ve vergiler öncesi kazançtır; yani EBIT.
Becton, Dickinson and Company için kazanç geçmişi 2000 - 2026
Her yılın sonundaki kazanç
Yıl Kazanç Değiştir
2026 (TTM) $2.06B 9.62%
2025 $1.88B -6.13%
2024 $2.01B 20.64%
2023 $1.66B -6.79%
2022 $1.78B 5.38%
2021 $1.69B 308.70%
2020 $414.00M -64.80%
2019 $1.18B 0.26%
2018 $1.17B 20.18%
2017 $976.00M -9.12%
2016 $1.07B 45.33%
2015 $739.00M -51.45%
2014 $1.52B 30.64%
2013 $1.17B -20.86%
2012 $1.47B -9.02%
2011 $1.62B 3.27%
2010 $1.57B -0.75%
2009 $1.58B 2.61%
2008 $1.54B 27.78%
2007 $1.20B 6.93%
2006 $1.13B 12.05%
2005 $1.00B 33.47%
2004 $752.87M 4.28%
2003 $721.96M 15.06%
2002 $627.47M 8.79%
2001 $576.75M 10.93%
2000 $519.93M 0.00%
Benzer şirketler veya rakipler için kazanç
Şirket Kazanç Kazanç Farkı Ülke
$3.31B 60.51%
US
$394.38M -80.88%
DE
$2.05B -0.80%
JP
$1.16B -43.77%
CH
$1.82B -11.84%
US